Eric Angevin
Impact in
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Cancer Research top 0.5%
- MicroRNA in disease regulation
Papers in
- Oncology 59
- Cancer Immunotherapy and Biomarkers 37
- CAR-T cell therapy research 14
- Immunology 44
- Immunotherapy and Immune Responses 32
- Immune Cell Function and Interaction 17
- T-cell and B-cell Immunology 13
- Co-authors
- Laurence Zitvogel (22 shared papers)Thomas Tursz (10 shared papers)Caroline Flament (12 shared papers)Graça Raposo (5 shared papers)Sebastián Amigorena (5 shared papers)Bernard Escudier (29 shared papers)Fabrice André (11 shared papers)Joseph Wolfers (3 shared papers)
- Journals
- Annals of Oncology (23 papers)Journal of Clinical Oncology (23 papers)International Journal of Cancer (10 papers)European Journal of Cancer (9 papers)The Journal of Immunology (6 papers)
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Eric Angevin
134 papers receiving 6.4k citations
Eric Angevin's Hit Papers
Peers
Comparison fields: 5 of 124
- Immunology 2.6k
- Cancer Research 1.5k
- Oncology 1.4k
- Molecular Biology 3.7k
- Hepatology 161
Countries citing papers authored by Eric Angevin
This map shows the geographic impact of Eric Angevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Angevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Angevin more than expected).
Fields of papers citing papers by Eric Angevin
This network shows the impact of papers produced by Eric Angevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Angevin. The network helps show where Eric Angevin may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Angevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming Hit paper breakdown → | 2001 | 1353 |
| 2 | Malignant effusions and immunogenic tumour-derived exosomes Hit paper breakdown → | 2002 | 797 |
| 3 | 2004 | 422 | |
| 4 | 2004 | 223 | |
| 5 | 2002 | 177 | |
| 6 | 2017 | 152 | |
| 7 | 2003 | 138 | |
| 8 | Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. | 2001 | 136 |
| 9 | 2004 | 113 | |
| 10 | 1993 | 112 | |
| 11 | 2007 | 109 | |
| 12 | 2018 | 109 | |
| 13 | 2018 | 108 | |
| 14 | 2013 | 104 | |
| 15 | 1994 | 96 | |
| 16 | 2004 | 87 | |
| 17 | 2002 | 86 | |
| 18 | 2004 | 85 | |
| 19 | 1999 | 80 | |
| 20 | 2022 | 73 |
About Eric Angevin
Eric Angevin is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 141 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (37 papers), Immunotherapy and Immune Responses (32 papers), Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (14 papers), Lung Cancer Treatments and Mutations (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (13 papers) and Extracellular vesicles in disease (11 papers). The work is most often cited by research in Immunology (2.6k citations), Cancer Research (1.5k citations), Oncology (1.4k citations), Molecular Biology (3.7k citations) and Hepatology (161 citations). Eric Angevin has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Laurence Zitvogel, Thomas Tursz, Caroline Flament, Graça Raposo, Sebastián Amigorena, Bernard Escudier, Fabrice André, Joseph Wolfers, Anne Lozier and Stéphanie Pouzieux. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, International Journal of Cancer, European Journal of Cancer and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.